Review



antibody against human igf2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems antibody against human igf2
    Antibody Against Human Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against human igf2/product/R&D Systems
    Average 93 stars, based on 28 article reviews
    antibody against human igf2 - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems antibody against human igf2
    Antibody Against Human Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against human igf2/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    antibody against human igf2 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems anti human igf2
    Anti Human Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human igf2/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    anti human igf2 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems mouse anti igf ii monoclonal antibody
    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic <t>protein;</t> <t>IGF-II,</t> insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .
    Mouse Anti Igf Ii Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti igf ii monoclonal antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mouse anti igf ii monoclonal antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems anti igf 1
    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic <t>protein;</t> <t>IGF-II,</t> insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .
    Anti Igf 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti igf 1/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    anti igf 1 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems polyclonal anti igf ii antibody
    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic <t>protein;</t> <t>IGF-II,</t> insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .
    Polyclonal Anti Igf Ii Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal anti igf ii antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    polyclonal anti igf ii antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Proteintech igf2
    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic <t>protein;</t> <t>IGF-II,</t> insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .
    Igf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/igf2/product/Proteintech
    Average 93 stars, based on 1 article reviews
    igf2 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti igf2
    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic <t>protein;</t> <t>IGF-II,</t> insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .
    Rabbit Anti Igf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti igf2/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti igf2 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Proteintech anti igf2
    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic <t>protein;</t> <t>IGF-II,</t> insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .
    Anti Igf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti igf2/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti igf2 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic protein; IGF-II, insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .

    Journal: bioRxiv

    Article Title: A Modular Bioinstructive Platform for Additive-Free, Topography-Driven Stem Cell Differentiation and Patterning

    doi: 10.1101/2025.07.11.664383

    Figure Lengend Snippet: A) Heatmap showing expression of selected genes associated with skeletogenesis across experimental conditions at days 3 and 14 post-seeding. B, C) Volcano plots displaying key differentially expressed genes associated with cytoskeleton, osteogenesis, and chondrogenesis in dimpled versus smooth microparticle cultures at day 3 (B) and day 14 (C) post-seeding (log 2 fold change > 1 and p adj < 0.05, N= 3 donors). D, E) Relative quantitative real-time PCR (qPCR) analysis of gene expression at specific time-points in serum-reduced medium, relative to 2D controls: RUNX2 (D; N= 5 donors) after 3 days, and SP7 (E; N= 5 donors) after 10 days. 2D positive control treated with 2 μM purmorphamine is shown as a reference point for RUNX2 expression. (F) Relative qPCR analysis of BGLAP expression after 10 days of either 300 nM KAAD-cyclopamine treatment or 0.06% ( v/v ) DMSO in serum-reduced medium, and relative to 2D vehicle-only controls (N= 5 donors). Statistical analysis was conducted using one-way ANOVA with Tukey’s multiple comparisons was applied. Values are presented as mean ± SD (** p < 0.01, *** p < 0.001, **** p < 0.0001). G, H) Representative maximum intensity projection confocal images of hMSCs stained for COL1A1 (green; G), and OCN (green; H) with nuclei counter-stained in blue (DAPI) after 10 days of culture (Scale bars: 50 μm). A single optical slice is used to represent brightfield for clarity. Abbreviations: SOX9, SRY-box transcription factor 9; COL2A1, collagen type II alpha 1 chain; COL10A1, collagen type x alpha 1 chain; COL1A1, collagen type I alpha 1; COL6A1, collagen type VI alpha 1 chain; ACAN, aggrecan; RUNX2, runt-related transcription factor 2; SP7, specificity protein 7, also known as osterix; MSX2, Msh homeobox 2; SPP1, secreted phosphoprotein 1, also known as osteopontin; POSTN, periostin; PAX9, paired box 9; BGLAP, bone gamma-carboxyglutamate protein, also known as osteocalcin; ALPL, alkaline phosphatase; TNC, tenascin-c; SCUBE3, signal peptide-CUB-EGF domain-containing protein 3 ; SERPINE2, serine protease inhibitor 2; GALNT1, N-acetylgalactosaminyltransferase 1; LEPR, leptin receptor; SOSTDC1, sclerostin domain-containing protein 1; CNMD , chondromodulin; BMP, bone morphogenetic protein; IGF-II, insulin-like growth factor 2; IGFBP, insulin-like growth factor binding protein; DAPI, 4′,6-Diamidino-2-phenylindole; OI media, Osteoinductive media; Pur, Purmorphamine; DIMP, Dimpled; SM, Smooth; DIMP_KD, Dimpled cultures treated with KAAD-cyclopamine .

    Article Snippet: Goat anti-IGF-I polyclonal antibody (1:5000; AF-291-SP, R&D Systems, RRID: AB_2122119), mouse anti-IGF-II monoclonal antibody (1:1000; MAB2921, R&D Systems, RRID: AB_2233454) and goat anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) polyclonal antibody (1:1000, AF5718, R&D Systems, RRID: AB_2278695) were used simultaneously for primary detection.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Gene Expression, Positive Control, Staining, Protease Inhibitor, Binding Assay

    A) Network analysis of the upstream regulatory network of insulin-like growth factor II (IGF-II) generated using IPA based on overlaid DEGs in hMSCs on dimpled versus smooth microparticles at day 14 post-seeding, highlighting transcriptional regulators, growth factors, and transmembrane receptors associated with IGF-II signalling. Nodes are colour-coded to represent expression levels: upregulated (red) and downregulated (green). Edges represent predicted relationships: activation (orange), findings inconsistent with expected relationships (yellow), and undefined effects (gray). This visualisation (created on BioRender.com ) focuses specifically on upstream regulators of IGF-II, with full post-trimming analysis provided in supplementary data. B) Representative multiplexed fluorescence Western blot performed at day 14 post-seeding hMSCs on smooth and dimpled microparticles against 2D controls, showing individual channels (i), and the overlaid image (GAPDH and IGF-I in blue, IGF-II in red). (C) Schematic depicting the proposed mechanism of topographically-guided osteoinduction by 3D dimpled topographical features in hMSCs. Abbreviations: IGFBP, insulin-like growth factor binding protein; FN1, fibronectin 1; PTCH1; Patched 1; GLI1, Glioma-associated oncogene homolog; ITGA5, Integrin subunit alpha 5; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase .

    Journal: bioRxiv

    Article Title: A Modular Bioinstructive Platform for Additive-Free, Topography-Driven Stem Cell Differentiation and Patterning

    doi: 10.1101/2025.07.11.664383

    Figure Lengend Snippet: A) Network analysis of the upstream regulatory network of insulin-like growth factor II (IGF-II) generated using IPA based on overlaid DEGs in hMSCs on dimpled versus smooth microparticles at day 14 post-seeding, highlighting transcriptional regulators, growth factors, and transmembrane receptors associated with IGF-II signalling. Nodes are colour-coded to represent expression levels: upregulated (red) and downregulated (green). Edges represent predicted relationships: activation (orange), findings inconsistent with expected relationships (yellow), and undefined effects (gray). This visualisation (created on BioRender.com ) focuses specifically on upstream regulators of IGF-II, with full post-trimming analysis provided in supplementary data. B) Representative multiplexed fluorescence Western blot performed at day 14 post-seeding hMSCs on smooth and dimpled microparticles against 2D controls, showing individual channels (i), and the overlaid image (GAPDH and IGF-I in blue, IGF-II in red). (C) Schematic depicting the proposed mechanism of topographically-guided osteoinduction by 3D dimpled topographical features in hMSCs. Abbreviations: IGFBP, insulin-like growth factor binding protein; FN1, fibronectin 1; PTCH1; Patched 1; GLI1, Glioma-associated oncogene homolog; ITGA5, Integrin subunit alpha 5; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase .

    Article Snippet: Goat anti-IGF-I polyclonal antibody (1:5000; AF-291-SP, R&D Systems, RRID: AB_2122119), mouse anti-IGF-II monoclonal antibody (1:1000; MAB2921, R&D Systems, RRID: AB_2233454) and goat anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) polyclonal antibody (1:1000, AF5718, R&D Systems, RRID: AB_2278695) were used simultaneously for primary detection.

    Techniques: Generated, Expressing, Activation Assay, Fluorescence, Western Blot, Binding Assay